Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rocky Mountain Alzheimer's Disease Center at the University of Colorado School of Medicine (RMADC at UCSOM) Longitudinal Biomarker and Clinical Phenotyping Study

NCT02612376 is registered in ClinicalTrials.gov with University of Colorado, Denver as lead sponsor.

NCT NCT02612376
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02612376 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rocky Mountain Alzheimer's Disease Center at the University of Colorado School of Medicine (RMADC at UCSOM) Longitudinal Biomarker and Clinical Phenotyping Study
Lead sponsor
University of Colorado, Denver
Phase
Observational
Overall status
Terminated
Start date
February 29, 2016
Completion date
May 31, 2025
Enrollment
800 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, down syndrome, mild cognitive impairment